Literature DB >> 30987913

Mechanical, inflammatory, and embolic complications of myocardial infarction: An emergency medicine review.

Tim Montrief1, William T Davis2, Alex Koyfman3, Brit Long4.   

Abstract

INTRODUCTION: Despite the declining incidence of coronary heart disease (CHD) in the United States, acute myocardial infarction (AMI) remains an important clinical entity, with many patients requiring emergency department (ED) management for mechanical, inflammatory, and embolic complications.
OBJECTIVE: This narrative review provides an evidence-based summary of the current data for the emergency medicine evaluation and management of post myocardial infarction mechanical, inflammatory, and embolic complications. DISCUSSION: While 30-day mortality rate after AMI has decreased in the past two decades, it remains significantly elevated at 7.8%, owing to a wide variety of subacute complications evolving over weeks. Mechanical complications such as ventricular free wall rupture, ventricular septal rupture, mitral valve regurgitation, and formation of left ventricular aneurysms carry significant morbidity. Additional complications include ischemic stroke, heart failure, renal failure, and cardiac dysrhythmias. This review provides several guiding principles for management of these complications. Understanding these complications and an approach to the management of various complications is essential to optimizing patient care.
CONCLUSIONS: Mechanical, inflammatory, and embolic complications of AMI can result in significant morbidity and mortality. Physicians must rapidly diagnose these conditions while evaluating for other diseases. In addition to understanding the natural progression of disease and performing a focused physical examination, an electrocardiogram and bedside echocardiogram provide quick, noninvasive determinations of the underlying pathophysiology. Management varies by presentation and etiology, but close consultation with cardiology and cardiac surgery is recommended. Published by Elsevier Inc.

Entities:  

Keywords:  Acute coronary syndrome; Complications; Mechanical complications; Myocardial infarction

Year:  2019        PMID: 30987913     DOI: 10.1016/j.ajem.2019.04.003

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

1.  Promoting roles of KLF5 in myocardial infarction in mice involving microRNA-27a suppression and the following GFPT2/TGF-β/Smad2/3 axis activation.

Authors:  Zhen Tian; Yan Zhang; Xueman Lyu
Journal:  Cell Cycle       Date:  2021-04-29       Impact factor: 4.534

2.  Post Myocardial Infarction Ventricular Septal Rupture Revealed By Acute Liver Failure Symptoms: A Case Report.

Authors:  Leila Haddar; Amine Bouchlarhem; Salma Bouyaddid; Asmae Kasimi; Noureddine Oulali; Noha El Ouafi; Nabila Ismaili
Journal:  Clin Med Insights Cardiol       Date:  2022-01-30

3.  Downregulation of Uncoupling Protein 2(UCP2) Mediated by MicroRNA-762 Confers Cardioprotection and Participates in the Regulation of Dynamic Mitochondrial Homeostasis of Dynamin Related Protein1 (DRP1) After Myocardial Infarction in Mice.

Authors:  Dehui Liu; Shangrong Zou; Guangnan Li; Qiyu Zhang; Chunlin Chen; Cuizhi Li; Huafeng Song; Shaoxian Chen; Jiawen Wang; Yueheng Wu; Youbin Liu
Journal:  Front Cardiovasc Med       Date:  2022-02-24

4.  Plasma Quantitative Lipid Profiles: Identification of CarnitineC18:1-OH, CarnitineC18:2-OH and FFA (20:1) as Novel Biomarkers for Pre-warning and Prognosis in Acute Myocardial Infarction.

Authors:  Jun Liu; Liangqiu Tang; Qiqi Lu; Yi Yu; Qiu-Gui Xu; Shanqiang Zhang; Yun-Xian Chen; Wen-Jie Dai; Ji-Cheng Li
Journal:  Front Cardiovasc Med       Date:  2022-04-11

Review 5.  Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.

Authors:  Ashis K Mukherjee; Dhruba J Chattopadhyay
Journal:  Phytother Res       Date:  2022-02-11       Impact factor: 6.388

6.  Effects and mechanisms of 6-hydroxykaempferol 3,6-di-O-glucoside-7-O-glucuronide from Safflower on endothelial injury in vitro and on thrombosis in vivo.

Authors:  Li-Wei Wang; Jiang-Feng He; Hai-Yan Xu; Peng-Fei Zhao; Jie Zhao; Cong-Cong Zhuang; Jian-Nan Ma; Chao-Mei Ma; Yong-Bin Liu
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

7.  Long non-coding RNA MCM3AP antisense RNA 1 silencing upregulates microRNA-24-3p to accelerate proliferation and migration of vascular endothelial cells in myocardial infarction rats by reducing EIF4G2.

Authors:  Ke Chen; Min Xi; Qihong Huang; Hao Wu; Guirong Lu; Shaohui Song; Wei Shi
Journal:  Cell Cycle       Date:  2022-02-03       Impact factor: 5.173

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.